Halozyme Therapeutics
- Kalinaki Hastings Marvins
Kalinaki Hastings Marvins serves as a Software Architect at Halozyme Therapeutics, Inc. and has been the CEO of HASTINGS INVESTMENTS since January 2019. With experience in both software architecture and executive leadership, Kalinaki Hastings Marvins combines technical expertise with strategic business oversight.
Org chart
Sign up to view 0 direct reports
Get started
Teams
This person is not in any teams
